The proteolytically stable peptidomimetic Pam-(Lys-βNSpe)6-NH2 selectively inhibits human neutrophil activation via formyl peptide receptor 2Sarah Line Skovbakke, Cláes Dahlgren, Huamei Forsman et al.|Biochemical Pharmacology|2014Cited by 22